Mr. Georg Beiske
Venture Partner of HealthCap, CEO and co-founder of Tribune Therapeutics. Prior to joining HealthCap as a medical associate in 2019, Mr. Beiske was a project manager leading a global development team at Bayer responsible for the technical development and manufacturing of a clinical stage radiolabeled antibody. Mr. Beiske joined Bayer following the acquisition of Healthcap portfolio company Algeta where he joined the late stage development of Xofigo in 2013. Mr. Beiske holds a Masters Degree in Pharmacy from the University of Oslo.